(Q93928982)
Statements
Efficacy and safety of cerivastatin, 0.2 mg and 0.4 mg, in patients with primary hypercholesterolaemia: a multinational, randomised, double-blind study. Cerivastatin Study Group (English)
L Ose
O Luurila
J Eriksson
A Olsson
H Lithell